APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nedaplatin Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nedaplatin Injection Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchNedaplatin Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Nedaplatin Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Nedaplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nedaplatin Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nedaplatin Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nedaplatin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nedaplatin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nedaplatin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nedaplatin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nedaplatin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nedaplatin Injection include Nichi-Iko Pharmaceutical, Jilin Hengjin Pharmaceutical, Aosaikang Pharma, Simcere and Qilu Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nedaplatin Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nedaplatin Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Nedaplatin Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nedaplatin Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nedaplatin Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nedaplatin Injection sales, projected growth trends, production technology, application and end-user industry.

Nedaplatin Injection Segment by Company

Nichi-Iko Pharmaceutical

Jilin Hengjin Pharmaceutical

Aosaikang Pharma

Simcere

Qilu Pharma

Nedaplatin Injection Segment by Type

10mg

50mg

100mg

Nedaplatin Injection Segment by Application

Cervical Cancer

Esophageal Cancer

Ovarian Cancer

Testicular Cancer

Lung Cancer

Bladder Cancer

Other

Nedaplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nedaplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nedaplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nedaplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nedaplatin Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nedaplatin Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nedaplatin Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nedaplatin Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Major Manufacturers Table 3. 50mg Major Manufacturers Table 4. 100mg Major Manufacturers Table 5. Global Nedaplatin Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cervical Cancer Major Manufacturers Table 7. Esophageal Cancer Major Manufacturers Table 8. Ovarian Cancer Major Manufacturers Table 9. Testicular Cancer Major Manufacturers Table 10. Lung Cancer Major Manufacturers Table 11. Bladder Cancer Major Manufacturers Table 12. Other Major Manufacturers Table 13. Nedaplatin Injection Industry Trends Table 14. Nedaplatin Injection Industry Drivers Table 15. Nedaplatin Injection Industry Opportunities and Challenges Table 16. Nedaplatin Injection Industry Restraints Table 17. Global Nedaplatin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Nedaplatin Injection Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Nedaplatin Injection Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Nedaplatin Injection Revenue Market Share by Region (2021-2026) Table 21. Global Nedaplatin Injection Revenue Market Share by Region (2027-2032) Table 22. Global Nedaplatin Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Nedaplatin Injection Sales by Region (2021-2026) & (K Units) Table 24. Global Nedaplatin Injection Sales by Region (2027-2032) & (K Units) Table 25. Global Nedaplatin Injection Sales Market Share by Region (2021-2026) Table 26. Global Nedaplatin Injection Sales Market Share by Region (2027-2032) Table 27. Global Nedaplatin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Nedaplatin Injection Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Nedaplatin Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Nedaplatin Injection Sales Market Share by Manufacturers (2021-2026) Table 31. Global Nedaplatin Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Nedaplatin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Nedaplatin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Nedaplatin Injection Manufacturers, Product Type & Application Table 35. Global Nedaplatin Injection Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Nedaplatin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Nedaplatin Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Nedaplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Nedaplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Nedaplatin Injection Revenue Market Share by Type (2021-2026) Table 42. Global Nedaplatin Injection Revenue Market Share by Type (2027-2032) Table 43. Global Nedaplatin Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 45. Global Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 46. Global Nedaplatin Injection Sales Market Share by Type (2021-2026) Table 47. Global Nedaplatin Injection Sales Market Share by Type (2027-2032) Table 48. Global Nedaplatin Injection Price by Type (2021-2026) & (US$/Unit) Table 49. Global Nedaplatin Injection Price by Type (2027-2032) & (US$/Unit) Table 50. Global Nedaplatin Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Nedaplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Nedaplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Nedaplatin Injection Revenue Market Share by Application (2021-2026) Table 54. Global Nedaplatin Injection Revenue Market Share by Application (2027-2032) Table 55. Global Nedaplatin Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 57. Global Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Nedaplatin Injection Sales Market Share by Application (2021-2026) Table 59. Global Nedaplatin Injection Sales Market Share by Application (2027-2032) Table 60. Global Nedaplatin Injection Price by Application (2021-2026) & (US$/Unit) Table 61. Global Nedaplatin Injection Price by Application (2027-2032) & (US$/Unit) Table 62. Nichi-Iko Pharmaceutical Company Information Table 63. Nichi-Iko Pharmaceutical Business Overview Table 64. Nichi-Iko Pharmaceutical Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Nichi-Iko Pharmaceutical Nedaplatin Injection Product Portfolio Table 66. Nichi-Iko Pharmaceutical Recent Development Table 67. Jilin Hengjin Pharmaceutical Company Information Table 68. Jilin Hengjin Pharmaceutical Business Overview Table 69. Jilin Hengjin Pharmaceutical Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Jilin Hengjin Pharmaceutical Nedaplatin Injection Product Portfolio Table 71. Jilin Hengjin Pharmaceutical Recent Development Table 72. Aosaikang Pharma Company Information Table 73. Aosaikang Pharma Business Overview Table 74. Aosaikang Pharma Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Aosaikang Pharma Nedaplatin Injection Product Portfolio Table 76. Aosaikang Pharma Recent Development Table 77. Simcere Company Information Table 78. Simcere Business Overview Table 79. Simcere Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Simcere Nedaplatin Injection Product Portfolio Table 81. Simcere Recent Development Table 82. Qilu Pharma Company Information Table 83. Qilu Pharma Business Overview Table 84. Qilu Pharma Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Qilu Pharma Nedaplatin Injection Product Portfolio Table 86. Qilu Pharma Recent Development Table 87. North America Nedaplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Nedaplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 90. North America Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 91. North America Nedaplatin Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Nedaplatin Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Nedaplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Nedaplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 96. North America Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 97. North America Nedaplatin Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Nedaplatin Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Nedaplatin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Nedaplatin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 104. North America Nedaplatin Injection Sales by Country (2027-2032) & (K Units) Table 105. North America Nedaplatin Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Nedaplatin Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 108. Canada Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 109. Europe Nedaplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Nedaplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 112. Europe Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 113. Europe Nedaplatin Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Nedaplatin Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Nedaplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Nedaplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 118. Europe Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 119. Europe Nedaplatin Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Nedaplatin Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Nedaplatin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Nedaplatin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 126. Europe Nedaplatin Injection Sales by Country (2027-2032) & (K Units) Table 127. Europe Nedaplatin Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Nedaplatin Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 130. France Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 131. U.K. Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 132. Italy Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 134. China Nedaplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 135. China Nedaplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 136. China Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 137. China Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 138. China Nedaplatin Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Nedaplatin Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Nedaplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 141. China Nedaplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 142. China Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 143. China Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 144. China Nedaplatin Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Nedaplatin Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Nedaplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Nedaplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 149. Asia Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 150. Asia Nedaplatin Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Nedaplatin Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Nedaplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Nedaplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 155. Asia Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 156. Asia Nedaplatin Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Nedaplatin Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Nedaplatin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Nedaplatin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 163. Asia Nedaplatin Injection Sales by Country (2027-2032) & (K Units) Table 164. Asia Nedaplatin Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Nedaplatin Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 167. South Korea Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 168. India Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 169. Australia Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Nedaplatin Injection Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Nedaplatin Injection Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Nedaplatin Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Nedaplatin Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Nedaplatin Injection Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Nedaplatin Injection Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Nedaplatin Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Nedaplatin Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Nedaplatin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Nedaplatin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Nedaplatin Injection Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Nedaplatin Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Nedaplatin Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 193. Argentina Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 194. Chile Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 195. Colombia Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 196. Peru Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 198. Israel Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 199. UAE Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 200. Turkey Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 201. Iran Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 202. Egypt Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Nedaplatin Injection Distributors List Table 206. Nedaplatin Injection Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Nedaplatin Injection Image Figure 2. Global Nedaplatin Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nedaplatin Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Image Figure 5. 50mg Image Figure 6. 100mg Image Figure 7. Global Nedaplatin Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nedaplatin Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cervical Cancer Image Figure 10. Esophageal Cancer Image Figure 11. Ovarian Cancer Image Figure 12. Testicular Cancer Image Figure 13. Lung Cancer Image Figure 14. Bladder Cancer Image Figure 15. Other Image Figure 16. Global Nedaplatin Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Nedaplatin Injection Revenue (2021-2032) & (US$ Million) Figure 18. Global Nedaplatin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Nedaplatin Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Nedaplatin Injection Revenue Market Share by Region (2021-2032) Figure 21. Global Nedaplatin Injection Sales (2021-2032) & (K Units) Figure 22. Global Nedaplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Nedaplatin Injection Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Nedaplatin Injection Sales YoY (2021-2032) & (K Units) Figure 25. Europe Nedaplatin Injection Sales YoY (2021-2032) & (K Units) Figure 26. China Nedaplatin Injection Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Nedaplatin Injection Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Nedaplatin Injection Sales YoY (2021-2032) & (K Units) Figure 29. Global Nedaplatin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Nedaplatin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Nedaplatin Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Nedaplatin Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Nedaplatin Injection Revenue Market Share by Type (2021-2032) Figure 35. Global Nedaplatin Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Nedaplatin Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Nedaplatin Injection Sales Market Share by Type (2021-2032) Figure 38. Global Nedaplatin Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Nedaplatin Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Nedaplatin Injection Revenue Market Share by Application (2021-2032) Figure 41. Global Nedaplatin Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Nedaplatin Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Nedaplatin Injection Sales Market Share by Application (2021-2032) Figure 44. North America Nedaplatin Injection Revenue Share by Type (2021-2032) Figure 45. North America Nedaplatin Injection Sales Share by Type (2021-2032) Figure 46. North America Nedaplatin Injection Revenue Share by Application (2021-2032) Figure 47. North America Nedaplatin Injection Sales Share by Application (2021-2032) Figure 48. North America Nedaplatin Injection Revenue Share by Country (2021-2032) Figure 49. North America Nedaplatin Injection Sales Share by Country (2021-2032) Figure 50. Europe Nedaplatin Injection Revenue Share by Type (2021-2032) Figure 51. Europe Nedaplatin Injection Sales Share by Type (2021-2032) Figure 52. Europe Nedaplatin Injection Revenue Share by Application (2021-2032) Figure 53. Europe Nedaplatin Injection Sales Share by Application (2021-2032) Figure 54. Europe Nedaplatin Injection Revenue Share by Country (2021-2032) Figure 55. Europe Nedaplatin Injection Sales Share by Country (2021-2032) Figure 56. China Nedaplatin Injection Revenue Share by Type (2021-2032) Figure 57. China Nedaplatin Injection Sales Share by Type (2021-2032) Figure 58. China Nedaplatin Injection Revenue Share by Application (2021-2032) Figure 59. China Nedaplatin Injection Sales Share by Application (2021-2032) Figure 60. Asia Nedaplatin Injection Revenue Share by Type (2021-2032) Figure 61. Asia Nedaplatin Injection Sales Share by Type (2021-2032) Figure 62. Asia Nedaplatin Injection Revenue Share by Application (2021-2032) Figure 63. Asia Nedaplatin Injection Sales Share by Application (2021-2032) Figure 64. Asia Nedaplatin Injection Revenue Share by Country (2021-2032) Figure 65. Asia Nedaplatin Injection Sales Share by Country (2021-2032) Figure 66. SAMEA Nedaplatin Injection Revenue Share by Type (2021-2032) Figure 67. SAMEA Nedaplatin Injection Sales Share by Type (2021-2032) Figure 68. SAMEA Nedaplatin Injection Revenue Share by Application (2021-2032) Figure 69. SAMEA Nedaplatin Injection Sales Share by Application (2021-2032) Figure 70. SAMEA Nedaplatin Injection Revenue Share by Country (2021-2032) Figure 71. SAMEA Nedaplatin Injection Sales Share by Country (2021-2032) Figure 72. Nedaplatin Injection Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Nedaplatin Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 50mg
  • 100mg
Applications
  • Cervical Cancer
  • Esophageal Cancer
  • Ovarian Cancer
  • Testicular Cancer
  • Lung Cancer
  • Bladder Cancer
  • Other
Companies covered
  • Nichi-Iko Pharmaceutical
  • Jilin Hengjin Pharmaceutical
  • Aosaikang Pharma
  • Simcere
  • Qilu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nedaplatin Injection Market by Type
  3. 1.2.1 Global Nedaplatin Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg
  5. 1.2.3 50mg
  6. 1.2.4 100mg
  7. 1.3 Nedaplatin Injection Market by Application
  8. 1.3.1 Global Nedaplatin Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cervical Cancer
  10. 1.3.3 Esophageal Cancer
  11. 1.3.4 Ovarian Cancer
  12. 1.3.5 Testicular Cancer
  13. 1.3.6 Lung Cancer
  14. 1.3.7 Bladder Cancer
  15. 1.3.8 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Nedaplatin Injection Market Dynamics
  1. 2.1 Nedaplatin Injection Industry Trends
  2. 2.2 Nedaplatin Injection Industry Drivers
  3. 2.3 Nedaplatin Injection Industry Opportunities and Challenges
  4. 2.4 Nedaplatin Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nedaplatin Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nedaplatin Injection Revenue by Region
  3. 3.2.1 Global Nedaplatin Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nedaplatin Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Nedaplatin Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Nedaplatin Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nedaplatin Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nedaplatin Injection Sales by Region
  9. 3.4.1 Global Nedaplatin Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nedaplatin Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Nedaplatin Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Nedaplatin Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nedaplatin Injection Revenue by Manufacturers
  2. 4.1.1 Global Nedaplatin Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nedaplatin Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nedaplatin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nedaplatin Injection Sales by Manufacturers
  6. 4.2.1 Global Nedaplatin Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nedaplatin Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nedaplatin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nedaplatin Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nedaplatin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nedaplatin Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nedaplatin Injection Manufacturers, Product Type & Application
  13. 4.7 Global Nedaplatin Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nedaplatin Injection Market CR5 and HHI
  16. 4.8.2 2025 Nedaplatin Injection Tier 1, Tier 2, and Tier 3
5 Nedaplatin Injection Market by Type
  1. 5.1 Global Nedaplatin Injection Revenue by Type
  2. 5.1.1 Global Nedaplatin Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nedaplatin Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nedaplatin Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nedaplatin Injection Sales by Type
  6. 5.2.1 Global Nedaplatin Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nedaplatin Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nedaplatin Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nedaplatin Injection Price by Type
6 Nedaplatin Injection Market by Application
  1. 6.1 Global Nedaplatin Injection Revenue by Application
  2. 6.1.1 Global Nedaplatin Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nedaplatin Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nedaplatin Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nedaplatin Injection Sales by Application
  6. 6.2.1 Global Nedaplatin Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nedaplatin Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nedaplatin Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nedaplatin Injection Price by Application
7 Company Profiles
  1. 7.1 Nichi-Iko Pharmaceutical
  2. 7.1.1 Nichi-Iko Pharmaceutical Company Information
  3. 7.1.2 Nichi-Iko Pharmaceutical Business Overview
  4. 7.1.3 Nichi-Iko Pharmaceutical Nedaplatin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Nichi-Iko Pharmaceutical Nedaplatin Injection Product Portfolio
  6. 7.1.5 Nichi-Iko Pharmaceutical Recent Developments
  7. 7.2 Jilin Hengjin Pharmaceutical
  8. 7.2.1 Jilin Hengjin Pharmaceutical Company Information
  9. 7.2.2 Jilin Hengjin Pharmaceutical Business Overview
  10. 7.2.3 Jilin Hengjin Pharmaceutical Nedaplatin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jilin Hengjin Pharmaceutical Nedaplatin Injection Product Portfolio
  12. 7.2.5 Jilin Hengjin Pharmaceutical Recent Developments
  13. 7.3 Aosaikang Pharma
  14. 7.3.1 Aosaikang Pharma Company Information
  15. 7.3.2 Aosaikang Pharma Business Overview
  16. 7.3.3 Aosaikang Pharma Nedaplatin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Aosaikang Pharma Nedaplatin Injection Product Portfolio
  18. 7.3.5 Aosaikang Pharma Recent Developments
  19. 7.4 Simcere
  20. 7.4.1 Simcere Company Information
  21. 7.4.2 Simcere Business Overview
  22. 7.4.3 Simcere Nedaplatin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Simcere Nedaplatin Injection Product Portfolio
  24. 7.4.5 Simcere Recent Developments
  25. 7.5 Qilu Pharma
  26. 7.5.1 Qilu Pharma Company Information
  27. 7.5.2 Qilu Pharma Business Overview
  28. 7.5.3 Qilu Pharma Nedaplatin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Qilu Pharma Nedaplatin Injection Product Portfolio
  30. 7.5.5 Qilu Pharma Recent Developments
8 North America
  1. 8.1 North America Nedaplatin Injection Market Size by Type
  2. 8.1.1 North America Nedaplatin Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Nedaplatin Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Nedaplatin Injection Price by Type (2021-2032)
  5. 8.2 North America Nedaplatin Injection Market Size by Application
  6. 8.2.1 North America Nedaplatin Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Nedaplatin Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Nedaplatin Injection Price by Application (2021-2032)
  9. 8.3 North America Nedaplatin Injection Market Size by Country
  10. 8.3.1 North America Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nedaplatin Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nedaplatin Injection Market Size by Type
  2. 9.1.1 Europe Nedaplatin Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nedaplatin Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Nedaplatin Injection Price by Type (2021-2032)
  5. 9.2 Europe Nedaplatin Injection Market Size by Application
  6. 9.2.1 Europe Nedaplatin Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nedaplatin Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Nedaplatin Injection Price by Application (2021-2032)
  9. 9.3 Europe Nedaplatin Injection Market Size by Country
  10. 9.3.1 Europe Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nedaplatin Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Nedaplatin Injection Market Size by Type
  2. 10.1.1 China Nedaplatin Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Nedaplatin Injection Sales by Type (2021-2032)
  4. 10.1.3 China Nedaplatin Injection Price by Type (2021-2032)
  5. 10.2 China Nedaplatin Injection Market Size by Application
  6. 10.2.1 China Nedaplatin Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Nedaplatin Injection Sales by Application (2021-2032)
  8. 10.2.3 China Nedaplatin Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nedaplatin Injection Market Size by Type
  2. 11.1.1 Asia Nedaplatin Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nedaplatin Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Nedaplatin Injection Price by Type (2021-2032)
  5. 11.2 Asia Nedaplatin Injection Market Size by Application
  6. 11.2.1 Asia Nedaplatin Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nedaplatin Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Nedaplatin Injection Price by Application (2021-2032)
  9. 11.3 Asia Nedaplatin Injection Market Size by Country
  10. 11.3.1 Asia Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nedaplatin Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nedaplatin Injection Market Size by Type
  2. 12.1.1 SAMEA Nedaplatin Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nedaplatin Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nedaplatin Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Nedaplatin Injection Market Size by Application
  6. 12.2.1 SAMEA Nedaplatin Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nedaplatin Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nedaplatin Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Nedaplatin Injection Market Size by Country
  10. 12.3.1 SAMEA Nedaplatin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nedaplatin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nedaplatin Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nedaplatin Injection Value Chain Analysis
  2. 13.1.1 Nedaplatin Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nedaplatin Injection Production Mode & Process
  6. 13.2 Nedaplatin Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nedaplatin Injection Distributors
  9. 13.2.3 Nedaplatin Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst